Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: Applied Research on Antimicrobial Resistance Prevention, Program Announcement #03120

---
identifier: "/us/fr/03-16407"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: Applied Research on Antimicrobial Resistance Prevention, Program Announcement #03120"
title_number: 0
title_name: "Federal Register"
section_number: "03-16407"
section_name: "Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: Applied Research on Antimicrobial Resistance Prevention, Program Announcement #03120"
positive_law: false
currency: "2003-06-30"
last_updated: "2003-06-30"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "03-16407"
document_type: "notice"
publication_date: "2003-06-30"
agencies:
  - "Health and Human Services Department"
  - "Centers for Disease Control and Prevention"
fr_citation: "68 FR 38711"
fr_volume: 68
---


#  Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: Applied Research on Antimicrobial Resistance Prevention, Program Announcement #03120

In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the following meeting:

*Name* : Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Applied Research on Antimicrobial Resistance, Program Announcement #03120.

*Times and Dates:* 9 a.m.-10 a.m., July 17, 2003 (Open), 10 a.m.-6 p.m., July 17, 2003 (Closed).

*Place* : National Center for Infectious Disease, Office of the Director, OAS Conference Room #3555, 35 Executive Park Drive, Atlanta, GA 30342, Telephone 404.498.3240.

*Status* : Portions of the meeting will be closed to the public in accordance with provisions set forth in section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92-463.

*Matters to be Discussed* : The meeting will include the review, discussion, and evaluation of applications received in response to Program Announcement #03120.

*Contact Person for More Information* : Mary L. Lerchen, Deputy Director, Office of Extramural Research, National Center for Infectious Diseases, CDC, 1600 Clifton Road, MS-C19, Atlanta, GA 30333, Telephone 404.639.0043.

The Director, Management Analysis and Services Office has been delegated the authority to sign *Federal Register* notices pertaining to announcements of meetings and other committee management activities, for both the CDC and the Agency for Toxic Substances and Disease Registry.

Dated: June 20, 2003.

Alvin Hall,

Director, Management Analysis and Services Office, Centers for Disease Control and Prevention (CDC).